We are live on ! Find out more
CRMD icon

CorMedix

33 hedge funds and large institutions have $10.3M invested in CorMedix in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

425% more capital invested

Capital invested by funds: $1.96M → $10.3M (+$8.33M)

200% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 4

0.15% more ownership

Funds ownership: 2.02%2.17% (+0.15%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

3% less funds holding

Funds holding: 3433 (-1)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

82% less call options, than puts

Call options by funds: $20K | Put options by funds: $113K

Holders
33
Holders Change
-1
Holders Change %
-2.94%
% of All Funds
0.75%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
4
Increased
12
Reduced
4
Closed
5
Calls
$20K
Puts
$113K
Net Calls
-$93K
Net Calls Change
-$74K

CRMD Hedge Fund Activity: Q3 2018 in Review

33 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q3 2018, worth a combined $10.3M — up 425% from $1.96M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of CRMD and 4 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 12 added.

The largest buyer was Vanguard Group, adding an estimated $436K. The largest seller was Franklin Resources, cutting an estimated $26K.

  • 33 institutional investors held CorMedix (CRMD) as of Q3 2018, down from 34 in Q2 2018.
  • Funds reported $10.3M of CorMedix stock for Q3 2018, up 425% quarter-over-quarter.
  • 4 funds opened new CorMedix positions in Q3 2018 and 5 closed out, a net change of -1 holder.
  • The largest CorMedix buyer in Q3 2018 was Vanguard Group, an estimated $436K added.
  • The largest CorMedix seller in Q3 2018 was Franklin Resources, an estimated $26K sold.

Based on aggregated 13F filings for Q3 2018.